Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 Aug;79(15):4747-50.
doi: 10.1073/pnas.79.15.4747.

Interleukin 1 can replace the requirement for I-A-positive cells in the proliferation of antigen-primed T cells

Interleukin 1 can replace the requirement for I-A-positive cells in the proliferation of antigen-primed T cells

S K Durum et al. Proc Natl Acad Sci U S A. 1982 Aug.

Abstract

Antigen-primed T cells have been shown to require I-region-compatible adherent cells, as well as the priming antigen, to proliferate in vitro. We postulated that the Ia-recognition event is required for the T cell to induce secretion of the monokine interleukin 1 (IL 1) from adherent cells; the conventionally held view is that Ia is directly required for T cell activation. Our hypothesis predicts that IL I could replace the requirement for Ia+ cells in T cell proliferation assays in vitro. To test this prediction, we depleted keyhole limpet hemocyanin (KLH)-primed C57BL/6 mouse lymph node cells of I-A+ cells by treating with monoclonal anti-I-Ab and complement. As expected, this treatment eliminated the ability of KLH to provoke a proliferative response by primed T cells. Proliferation was restored by providing exogenous IL 1, but only in conjunction with added KLH. The proliferative response of primed T cells could also be blocked by adding anti-I-Ab to culture, and this inhibition could similarly be reversed by providing IL 1 in the presence of the specific antigen KLH. On the basis of these findings we propose a model of T cell activation and discuss its implications.

PubMed Disclaimer

References

    1. Mol Immunol. 1980 May;17(5):571-7 - PubMed
    1. J Immunol. 1976 May;116(5):1482-9 - PubMed
    1. J Immunol. 1978 Nov;121(5):1981-9 - PubMed
    1. J Immunol. 1980 May;124(5):2231-9 - PubMed
    1. Proc Natl Acad Sci U S A. 1968 Oct;61(2):542-7 - PubMed

Publication types